ProfileGDS4132 / 233033_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 51% 50% 31% 33% 44% 47% 46% 44% 39% 32% 38% 43% 36% 34% 34% 37% 38% 30% 35% 39% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101138.53451
GSM201543Muscle PCOS pioglitazone 121126.0250
GSM201544Muscle PCOS pioglitazone 16178.896831
GSM201545Muscle PCOS pioglitazone 20190.030633
GSM201829Muscle PCOS pioglitazone 231124.55344
GSM201830Muscle PCOS pioglitazon 251128.43947
GSM201831Muscle PCOS pioglitazone 271122.18746
GSM201832Muscle PCOS pioglitazone 31114.95444
GSM201833Muscle PCOS pioglitazone 4193.36439
GSM201834Muscle PCOS pioglitazone 8176.254132
GSM201835Muscle PCOS after pioglitazone 10284.337938
GSM201836Muscle PCOS after pioglitazone 122101.33243
GSM201837Muscle PCOS after pioglitazone 16275.56536
GSM201838Muscle PCOS after pioglitazone 20275.993634
GSM201839Muscle PCOS after pioglitazone 23278.293434
GSM201840Muscle PCOS after pioglitazone 25290.176137
GSM201841Muscle PCOS after pioglitazone 27282.573638
GSM201842Muscle PCOS after pioglitazone 3257.250730
GSM201843Muscle PCOS after pioglitazone 4284.660335
GSM201844Muscle PCOS after pioglitazone 8293.941339